Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.
Read Full NewsAvadel's REVITALYZ trial for Lumryz in idiopathic hypersomnia shows promise, potentially offering a new treatment option for this underserved condition.
NeurologyLive® provided in-depth coverage of conferences in 2025, highlighting advancements in diagnostics, treatments, and multidisciplinary care across multiple neurological conditions.
Ophthalmology in 2025: Year in Review
Increases in Physician Attrition Rates Could Worsen Shortages
Hormonal Disorders in 2025: Year in Review
1.
Obesity linked to subsequent neoplasms in childhood cancer survivors
2.
Investigations may result in novel combination therapies for early-stage lung cancers.
3.
A new theranostic drug targets different cancer types.
4.
High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment
5.
After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.
1.
Early Detection of Breast Cancer: Signs, Symptoms, and Screening Methods
2.
Radiation in Oncology: Advances, Applications, and Accessibility
3.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
4.
Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals
5.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Thromboprophylaxis In Medical Settings- An Update
4.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
5.
Should We Use DARA Up Front As First-Line Therapy in MM?
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge